Published in J Neuroimmune Pharmacol on June 03, 2017
Immunology: Nervous crosstalk to make antibodies. Nature (2017) 0.75
Potential Roles of Peripheral Dopamine in Tumor Immunity. J Cancer (2017) 0.75
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol (2010) 24.08
Pattern recognition receptors and inflammation. Cell (2010) 21.05
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA (2016) 17.49
The pathogenesis of rheumatoid arthritis. N Engl J Med (2011) 12.16
Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity (2011) 11.15
Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol (2003) 11.11
Dendritic cells: specialized and regulated antigen processing machines. Cell (2001) 10.44
Functions of natural killer cells. Nat Immunol (2008) 9.88
Dopamine receptors: from structure to function. Physiol Rev (1998) 8.90
Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med (2010) 8.58
Astrocytes: biology and pathology. Acta Neuropathol (2009) 8.43
Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol (2013) 7.10
The eosinophil. Annu Rev Immunol (2006) 7.06
Physiology of microglia. Physiol Rev (2011) 6.99
Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol (2011) 6.96
Double-Blind Prospective Randomized Controlled Trial of Dopamine Versus Epinephrine as First-Line Vasoactive Drugs in Pediatric Septic Shock. Crit Care Med (2015) 6.64
The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev (2011) 5.25
Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog Neurobiol (2005) 4.96
Antibacterial peptides: basic facts and emerging concepts. J Intern Med (2003) 4.44
Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature (1995) 4.18
Neutrophil function: from mechanisms to disease. Annu Rev Immunol (2012) 3.63
Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol (2003) 3.56
Natural-killer cells and dendritic cells: "l'union fait la force". Blood (2005) 3.10
EFFECT OF DOPAMINE IN MAN: AUGMENTATION OF SODIUM EXCRETION, GLOMERULAR FILTRATION RATE, AND RENAL PLASMA FLOW. J Clin Invest (1964) 2.97
Microglia: intrinsic immuneffector cell of the brain. Brain Res Brain Res Rev (1995) 2.92
Distinct functions of the two isoforms of dopamine D2 receptors. Nature (2000) 2.83
Astrocyte dysfunction in neurological disorders: a molecular perspective. Nat Rev Neurosci (2006) 2.76
Dopamine mediates vagal modulation of the immune system by electroacupuncture. Nat Med (2014) 2.45
Emerging roles of astrocytes in neural circuit development. Nat Rev Neurosci (2013) 2.45
Astrocytes and disease: a neurodevelopmental perspective. Genes Dev (2012) 2.28
Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis*. Crit Care Med (2012) 2.06
Analysis of full and partial agonists binding to beta2-adrenergic receptor suggests a role of transmembrane helix V in agonist-specific conformational changes. J Mol Recognit (2009) 2.05
Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDS. J Immunol (2009) 1.85
Dopamine receptor subtypes: beyond the D1/D2 classification. Trends Pharmacol Sci (1990) 1.85
Eosinophilic myocarditis in patients awaiting heart transplantation. Crit Care Med (2004) 1.61
Neutrophils promote Alzheimer's disease-like pathology and cognitive decline via LFA-1 integrin. Nat Med (2015) 1.61
Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder? Int Rev Neurobiol (2007) 1.60
Methamphetamine enhances HIV infection of macrophages. Am J Pathol (2008) 1.60
Neutrophils: Cinderella of innate immune system. Int Immunopharmacol (2010) 1.59
Evidence against dopamine D1/D2 receptor heteromers. Mol Psychiatry (2015) 1.56
Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine. J Clin Endocrinol Metab (2005) 1.55
Activation of the reward system boosts innate and adaptive immunity. Nat Med (2016) 1.51
Effects of toxoplasma on human behavior. Schizophr Bull (2007) 1.51
Nonredundant roles of basophils in immunity. Annu Rev Immunol (2011) 1.49
Functions of astrocytes and their potential as therapeutic targets. Neurotherapeutics (2010) 1.44
Monocytes and macrophages regulate immunity through dynamic networks of survival and cell death. J Innate Immun (2010) 1.44
The immunoregulatory role of dopamine: an update. Brain Behav Immun (2009) 1.42
The multifactorial role of neutrophils in rheumatoid arthritis. Nat Rev Rheumatol (2014) 1.41
Microglia development and function. Annu Rev Immunol (2014) 1.41
Dopamine receptors and brain function. Neuropharmacology (1996) 1.41
Potential clozapine target sites on peripheral hematopoietic cells and stromal cells of the bone marrow. Pharmacogenomics J (2003) 1.41
Radical changes in multiple sclerosis pathogenesis. Biochim Biophys Acta (2010) 1.40
Bromocriptine Mesylate Attenuates Amyotrophic Lateral Sclerosis: A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Research in Japanese Patients. PLoS One (2016) 1.39
Suppression of macrophage activation and T-lymphocyte function in hypoprolactinemic mice. Science (1988) 1.39
Neutrophils: Between host defence, immune modulation, and tissue injury. PLoS Pathog (2015) 1.35
Innate immunity in Alzheimer's disease. Nat Immunol (2015) 1.33
Meningeal mast cells affect early T cell central nervous system infiltration and blood-brain barrier integrity through TNF: a role for neutrophil recruitment? J Immunol (2010) 1.31
The effect of Toxoplasma gondii on animal behavior: playing cat and mouse. Schizophr Bull (2007) 1.31
The role of the innate immune system in psychiatric disorders. Mol Cell Neurosci (2012) 1.27
Influence of latent Toxoplasma infection on human personality, physiology and morphology: pros and cons of the Toxoplasma-human model in studying the manipulation hypothesis. J Exp Biol (2013) 1.27
Recognition of tumors by the innate immune system and natural killer cells. Adv Immunol (2014) 1.27
Innate immunity in amyotrophic lateral sclerosis. Biochim Biophys Acta (2006) 1.26
Overview of complement activation and regulation. Semin Nephrol (2013) 1.26
Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome. Cell (2015) 1.25
Dopamine, a neurotransmitter, influences the immune system. J Neuroimmunol (2000) 1.25
Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: a flow cytometric study. J Neuroimmunol (2002) 1.25
Substantial production of dopamine in the human gastrointestinal tract. J Clin Endocrinol Metab (1997) 1.24
Dopamine and noradrenaline control distinct functions in rodent microglial cells. Mol Cell Neurosci (2005) 1.24
Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis. J Neuroimmune Pharmacol (2013) 1.23
Monocyte maturation, HIV susceptibility, and transmigration across the blood brain barrier are critical in HIV neuropathogenesis. J Leukoc Biol (2012) 1.22
Concurrent activation of dopamine D1 and D2 receptors is required to evoke neural and behavioral phenotypes of cocaine sensitization. J Neurosci (2002) 1.21
Catecholamines in a macrophage cell line. J Neuroimmunol (2003) 1.21
Extrapyramidal signs in patients with probable Alzheimer disease. Arch Neurol (1997) 1.20
Distinct roles of dopamine D2L and D2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and postsynaptic sites. Proc Natl Acad Sci U S A (2003) 1.20
Calcium signaling by dopamine D5 receptor and D5-D2 receptor hetero-oligomers occurs by a mechanism distinct from that for dopamine D1-D2 receptor hetero-oligomers. Mol Pharmacol (2009) 1.19
Human immunodeficiency virus (HIV) infection of human macrophages is increased by dopamine: a bridge between HIV-associated neurologic disorders and drug abuse. Am J Pathol (2009) 1.18
Cells of the synovium in rheumatoid arthritis. Dendritic cells. Arthritis Res Ther (2007) 1.16
Toxoplasma gondii infection and behaviour - location, location, location? J Exp Biol (2013) 1.14
Dopamine suppresses IL-12 p40 production by lipopolysaccharide-stimulated macrophages via a beta-adrenoceptor-mediated mechanism. J Neuroimmunol (2002) 1.12
Adenosine A2A and dopamine D2 heteromeric receptor complexes and their function. J Mol Neurosci (2005) 1.12
Innate immune cells in liver inflammation. Mediators Inflamm (2012) 1.11
Unraveling the neuroimmune mechanisms for the HIV-1-associated cognitive/motor complex. Immunol Today (1995) 1.11
Molecular neurobiology of dopaminergic receptors. Int Rev Neurobiol (1993) 1.11
Complexity of dendritic cell subsets and their function in the host immune system. Immunology (2011) 1.11
The innate immune system in demyelinating disease. Immunol Rev (2012) 1.10
The innate immune system in rheumatoid arthritis. Arthritis Rheum (2001) 1.10
Innate immune control of HIV. Cold Spring Harb Perspect Med (2012) 1.09
Human NK cells: from surface receptors to the therapy of leukemias and solid tumors. Front Immunol (2014) 1.09
Minireview: new roles for peripheral dopamine on metabolic control and tumor growth: let's seek the balance. Endocrinology (2010) 1.08
Course and prognosis of human immunodeficiency virus-associated nephropathy. Am J Med (1989) 1.07
Neutrophils in multiple sclerosis are characterized by a primed phenotype. J Neuroimmunol (2011) 1.07
Dopamine D1-D2 receptor heteromer signaling pathway in the brain: emerging physiological relevance. Mol Brain (2011) 1.06
Innate immunity and rheumatoid arthritis. Rheum Dis Clin North Am (2010) 1.06
Role of dopamine in the physiology of T-cells and dendritic cells. J Neuroimmunol (2009) 1.06
Astrocytes: a central element in neurological diseases. Acta Neuropathol (2015) 1.06
Role of neutrophils in systemic autoimmune diseases. Arthritis Res Ther (2013) 1.05
Astrocytes Control Synapse Formation, Function, and Elimination. Cold Spring Harb Perspect Biol (2015) 1.05
Innate immunity in Alzheimer's disease: a complex affair. CNS Neurol Disord Drug Targets (2013) 1.05